STANDARD BIOTOOLS INC. (LAB) Form 10-K Annual Reports
STANDARD BIOTOOLS INC. (LAB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LAB
CIK: 1162194
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerHitean Parmar
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-4/A | 2026-10-09 | — | S-4/A | 0001140361-26-039290 | View SEC Doc Filr Page |
| 425 | 2026-10-05 | — | 425 | 0001140361-26-038625 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001140361-26-038624 | View SEC Doc Filr Page |
| 425 | 2026-09-30 | — | 425 | 0001140361-26-038111 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001140361-26-038110 | View SEC Doc Filr Page |
| S-4/A | 2026-09-09 | — | S-4/A | 0001140361-26-036084 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363767 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363762 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | 4 | 0001193125-26-363758 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001385702-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001019056-26-000130 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | FORM S-8 | 0001104659-26-091220 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | FORM S-8 | 0001104659-26-091219 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335103 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335106 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 | 0001193125-26-333225 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-30 | — | SCHEDULE 13G/A Filing | 0002012383-26-003074 | View SEC Doc Filr Page |
| 425 | 2026-07-29 | — | 425 | 0001140361-26-029965 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-29 | 2026-07-28 | 8-K/A | 0001140361-26-029964 | View SEC Doc Filr Page |
| 425 | 2026-07-28 | — | 425 | 0001140361-26-029844 | View SEC Doc Filr Page |
| 425 | 2026-07-28 | — | 425 | 0001140361-26-029842 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-24 | 8-K | 0001140361-26-029841 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 | 0001193125-26-318442 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-22 | 8-K | 0001193125-26-316183 | View SEC Doc Filr Page |
| 425 | 2026-07-20 | — | 425 | 0001140361-26-028877 | View SEC Doc Filr Page |